Le Lézard

Travere Therapeutics Announces Full FDA Approval of FILSPARI® (sparsentan), the First and Only Approved Medicine for FSGS

Travere Therapeutics, Inc., today announced that the U.S. Food and Drug Administration (FDA) has approved FILSPARI® ...